glp-1 drugs eli lilly FDA approves tirzepatide, Lilly's new type 2 diabetes drug, and the company shares an estimated price Lilly's Double-Beat Widens the GLP-1
Description
emDOCs.net

doi: 10.1038/nm.2886 96 KappeC.TracyL

Neurogastroenterol Motil 2017;29

BMJ 353, i1585